Diet macronutrients composition in nonalcoholic fatty liver disease: A review on the related documents

Hepatitis Monthly

Volumn 14, Issue 2, 2014, Pages

  Hashemi Kani, Ali ^a,b   Alavian, Seyed Moayed ^c   Haghighatdoost, Fahimeh ^a,b   Azadbakht, Leila ^a,b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Middle East Liver Diseases Center   (Iran)

Author keywords

Carbohydrates; Food; Intra Abdominal Fat; Non alcoholic Fatty Liver Disease; Proteins

Indexed keywords

ACYL COENZYME A DESATURASE; ALANINE AMINOTRANSFERASE; ASPARTAME; BRANCHED CHAIN AMINO ACID; FIBROBLAST GROWTH FACTOR 21; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE 6 PHOSPHATASE; SATURATED FATTY ACID; TRANS FATTY ACID; TUMOR NECROSIS FACTOR ALPHA;

CALORIC INTAKE; CARBOHYDRATE INTAKE; DIET; DIET THERAPY; HUMAN; HYPERGLYCEMIA; INTESTINE FLORA; INTRAABDOMINAL FAT; LIPID STORAGE; LOW CALORY DIET; MACRONUTRIENT; NONALCOHOLIC FATTY LIVER; NONHUMAN; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SOFT DRINK;

EID: 84895491638     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/hepatmon.10939     Document Type: Review

References (80)

1. McCullough AJ. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin Liver Dis.2004;8(3):521-33. [DOI] [PubMed]
2. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346(16):1221-31. [DOI] [PubMed]
3. de Alwis NM, Day CP. Non-alcoholic fatty liver disease: the mist gradually clears. J Hepatol. 2008;48 Suppl 1:S104-12. [DOI] [PubMed]
4. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology. 2005;42(1):44-52. [DOI] [PubMed]
5. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40(6):1387-95. [DOI] [PubMed]
6. Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol. 2006;40 Suppl 1:S5-10. [DOI] [PubMed]
7. Clark JM, Diehl AM. Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis. JAMA.2003;289(22):3000-4. [DOI] [PubMed]
8. Naghavi M. Etiology of death in 18 provinces of Iran in year 2001. Tehran: Ministry of Health and Medical Education IR Iran; 2003. 21 Pp.
9. Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology. 1998;114(4):842-5. [PubMed]
10. Jamali R, Khonsari M, Merat S, Khoshnia M, Jafari E, Bahram Kalhori A, Et al. Persistent alanine aminotransferase elevation among the general Iranian population: prevalence and causes. World J Gastroenterol. 2008;14(18):2867-71. [PubMed]
11. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology. 1990;12(5):1106-10. [PubMed]
12. Diehl AM. Tumor necrosis factor and its potential role in insulin resistance and nonalcoholic fatty liver disease. Clin Liver Dis. 2004;8(3):619-38. [DOI] [PubMed]
13. Allard JP. Other disease associations with non-alcoholic fatty liver disease (NAFLD). Best Pract Res Clin Gastroenterol. 2002;16(5):783-95. [PubMed]
14. Medina J, Fernandez-Salazar LI, Garcia-Buey L, Moreno-Otero R. Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis. Diabetes Care. 2004;27(8):2057-66. [PubMed]
15. Nardone G, Rocco A. Probiotics: a potential target for the prevention and treatment of steatohepatitis. J Clin Gastroenterol. 2004;38(6 Suppl):S121-2. [PubMed]
16. Mouzaki M, Allard JP. The role of nutrients in the development, progression, and treatment of nonalcoholic fatty liver disease. J Clin Gastroenterol. 2012;46(6):457-67. [DOI] [PubMed]
17. Shi X, Wahlang B, Wei X, Yin X, Falkner KC, Prough RA, Et al. Metabolomic analysis of the effects of polychlorinated biphenyls in nonalcoholic fatty liver disease. J Proteome Res. 2012;11(7):3805-15. [DOI] [PubMed]
18. Agius L. High-carbohydrate diets induce hepatic insulin resistance to protect the liver from substrate overload. Biochem Pharmacol. 2013;85(3):306-12. [DOI] [PubMed]
19. Nazarenko LI, Petrova Iu N, Raikhel'son KL, Baranovskii A. [Nutrition mistakes in patients with nonalcoholic fatty liver disease and the ways of correction]. Eksp Klin Gastroenterol. 2012;;(2):19-24. [PubMed]
20. Schugar RC, Crawford PA. Low-carbohydrate ketogenic diets, glucose homeostasis, and nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care. 2012;15(4):374-80. [DOI] [PubMed]
21. Liu T, Yang LL, Zhang L, Song HY, Li DF, Ji G. [Comparative study on the effects of different therapeutic methods in preventing and treating nonalcoholic fatty liver in rats]. Zhong Xi Yi Jie He Xue Bao. 2012;10(10):1120-6. [PubMed]
22. Morita M, Ishida N, Uchiyama K, Yamaguchi K, Itoh Y, Shichiri M, Et al. Fatty liver induced by free radicals and lipid peroxidation. Free Radic Res. 2012;46(6):758-65. [DOI] [PubMed]
23. van der Meer RW, Hammer S, Lamb HJ, Frolich M, Diamant M, Rijzewijk LJ, Et al. Effects of short-term high-fat, high-energy diet on hepatic and myocardial triglyceride content in healthy men. J Clin Endocrinol Metab.2008;93(7):2702-8. [DOI] [PubMed]
24. Westerbacka J, Lammi K, Hakkinen AM, Rissanen A, Salminen I, Aro A, Et al. Dietary fat content modifies liver fat in overweight nondiabetic subjects. J Clin Endocrinol Metab. 2005;90(5):2804-9. [DOI] [PubMed]
25. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology. 2001;120(5):1183-92. [DOI] [PubMed]
26. Storlien LH, Kraegen EW, Chisholm DJ, Ford GL, Bruce DG, Pascoe WS. Fish oil prevents insulin resistance induced by high-fat feeding in rats. Science. 1987;237(4817):885-8. [PubMed]
27. Tarantino G, Conca P, Pasanisi F, Ariello M, Mastrolia M, Arena A, Et al. Could inflammatory markers help diagnose nonalcoholic steatohepatitis? Eur J Gastroenterol Hepatol. 2009;21(5):504-11. [DOI] [PubMed]
28. Caporaso N, Morisco F, Camera S, Graziani G, Donnarumma L, Ritieni A. Dietary approach in the prevention and treatment of NAFLD. Front Biosci (Landmark Ed). 2012;17:2259-68. [PubMed]
29. Cortez-Pinto H, Jesus L, Barros H, Lopes C, Moura MC, Camilo ME. How different is the dietary pattern in non-alcoholic steatohepatitis patients? Clin Nutr. 2006;25(5):816-23. [DOI] [PubMed]
30. Kim SP, Ellmerer M, Van Citters GW, Bergman RN. Primacy of hepatic insulin resistance in the development of the metabolic syndrome induced by an isocaloric moderate-fat diet in the dog. Diabetes. 2003;52(10):2453-60. [PubMed]
31. Yilmaz Y. Review article: fructose in non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2012;35(10):1135-44. [DOI] [PubMed]
32. Utzschneider KM, Bayer-Carter JL, Arbuckle MD, Tidwell JM, Richards TL, Craft S. Beneficial effect of a weight-stable, low-fat/low-saturated fat/low-glycaemic index diet to reduce liver fat in older subjects. Br J Nutr.2013;109(6):1096-104. [DOI] [PubMed]
33. Zelber-Sagi S, Nitzan-Kaluski D, Goldsmith R, Webb M, Blendis L, Halpern Z, Et al. Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study. J Hepatol. 2007;47(5):711-7. [DOI] [PubMed]
34. Machado RM, Stefano JT, Oliveira CP, Mello ES, Ferreira FD, Nunes VS, Et al. Intake of trans fatty acids causes nonalcoholic steatohepatitis and reduces adipose tissue fat content. J Nutr. 2010;140(6):1127-32. [DOI] [PubMed]
35. Shertzer HG, Woods SE, Krishan M, Genter MB, Pearson KJ. Dietary whey protein lowers the risk for metabolic disease in mice fed a high-fat diet. J Nutr. 2011;141(4):582-7. [DOI] [PubMed]
36. Yang HY, Tzeng YH, Chai CY, Hsieh AT, Chen JR, Chang LS, Et al. Soy protein retards the progression of non-alcoholic steatohepatitis via improvement of insulin resistance and steatosis. Nutrition. 2011;27(9):943-8. [DOI] [PubMed]
37. Assy N, Nasser G, Kamayse I, Nseir W, Beniashvili Z, Djibre A, Et al. Soft drink consumption linked with fatty liver in the absence of traditional risk factors. Can J Gastroenterol. 2008;22(10):811-6. [PubMed]
38. Ludwig DS, Peterson KE, Gortmaker SL. Relation between consumption of sugar-sweetened drinks and childhood obesity: a prospective, observational analysis. Lancet. 2001;357(9255):505-8. [DOI] [PubMed]
39. Popkin BM, Armstrong LE, Bray GM, Caballero B, Frei B, Willett WC. A new proposed guidance system for beverage consumption in the United States. Am J Clin Nutr. 2006;83(3):529-42. [PubMed]
40. Trocho C, Pardo R, Rafecas I, Virgili J, Remesar X, Fernandez-Lopez JA, Et al. Formaldehyde derived from dietary aspartame binds to tissue components in vivo. Life Sci. 1998;63(5):337-49. [PubMed]
41. Nomura K, Yamanouchi T. The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease. J Nutr Biochem. 2012;23(3):203-8. [DOI] [PubMed]
42. Volynets V, Machann J, Kuper MA, Maier IB, Spruss A, Konigsrainer A, Et al. A moderate weight reduction through dietary intervention decreases hepatic fat content in patients with non-alcoholic fatty liver disease (NAFLD): a pilot study. Eur J Nutr. 2013;52(2):527-35. [DOI] [PubMed]
43. Haub S, Kanuri G, Volynets V, Brune T, Bischoff SC, Bergheim I. Serotonin reuptake transporter (SERT) plays a critical role in the onset of fructose-induced hepatic steatosis in mice. Am J Physiol Gastrointest Liver Physiol.2010;298(3):G335-44. [DOI] [PubMed]
44. Song M, Schuschke DA, Zhou Z, Chen T, Pierce WM, Jr., Wang R, Et al. High fructose feeding induces copper deficiency in Sprague-Dawley rats: a novel mechanism for obesity related fatty liver. J Hepatol. 2012;56(2):433-40. [DOI] [PubMed]
45. Fraser A, Abel R, Lawlor DA, Fraser D, Elhayany A. A modified Mediterranean diet is associated with the greatest reduction in alanine aminotransferase levels in obese type 2 diabetes patients: results of a quasi-randomised controlled trial. Diabetologia. 2008;51(9):1616-22. [DOI] [PubMed]
46. Goletzke J, Buyken AE, Gopinath B, Rochtchina E, Barclay AW, Cheng G, Et al. Carbohydrate quality is not associated with liver enzyme activity and plasma TAG and HDL concentrations over 5 years in an older population. Br J Nutr. 2013;110(5):918-25. [DOI] [PubMed]
47. Schwarz JM, Linfoot P, Dare D, Aghajanian K. Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. Am J Clin Nutr. 2003;77(1):43-50. [PubMed]
48. Cussons AJ, Watts GF, Mori TA, Stuckey BG. Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: a randomized controlled trial employing proton magnetic resonance spectroscopy. J Clin Endocrinol Metab. 2009;94(10):3842-8. [DOI] [PubMed]
49. Parker HM, Johnson NA, Burdon CA, Cohn JS, O'Connor HT, George J. Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol. 2012;56(4):944-51. [DOI] [PubMed]
50. Capanni M, Calella F, Biagini MR, Genise S, Raimondi L, Bedogni G, Et al. Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study. Aliment Pharmacol Ther. 2006;23(8):1143-51. [DOI] [PubMed]
51. Levy JR, Clore JN, Stevens W. Dietary n-3 polyunsaturated fatty acids decrease hepatic triglycerides in Fischer 344 rats. Hepatology. 2004;39(3):608-16. [DOI] [PubMed]
52. Jump DB. N-3 polyunsaturated fatty acid regulation of hepatic gene transcription. Curr Opin Lipidol.2008;19(3):242-7. [DOI] [PubMed]
53. Qi K, Fan C, Jiang J, Zhu H, Jiao H, Meng Q, Et al. Omega-3 fatty acid containing diets decrease plasma triglyceride concentrations in mice by reducing endogenous triglyceride synthesis and enhancing the blood clearance of triglyceride-rich particles. Clin Nutr. 2008;27(3):424-30. [DOI] [PubMed]
54. Hancu N, Roman G, Nita C, Negrean M. Metabolic syndrome--practical approach. Rom J Intern Med.2004;42(2):237-45. [PubMed]
55. Bozzetto L, Prinster A, Annuzzi G, Costagliola L, Mangione A, Vitelli A, Et al. Liver fat is reduced by an isoenergetic MUFA diet in a controlled randomized study in type 2 diabetic patients. Diabetes Care. 2012;35(7):1429-35. [DOI] [PubMed]
56. Clark SJ, Shojaee-Moradie F, Croos P, Seed PT, Umpleby AM, Wendon JA, Et al. Temporal changes in insulin sensitivity following the development of acute liver failure secondary to acetaminophen. Hepatology. 2001;34(1):109-15. [DOI] [PubMed]
57. Serrano-Martinez M, Palacios M, Martinez-Losa E, Lezaun R, Maravi C, Prado M, Et al. A Mediterranean dietary style influences TNF-alpha and VCAM-1 coronary blood levels in unstable angina patients. Eur J Nutr.2005;44(6):348-54. [DOI] [PubMed]
58. Madigan C, Ryan M, Owens D, Collins P, Tomkin GH. Dietary unsaturated fatty acids in type 2 diabetes: higher levels of postprandial lipoprotein on a linoleic acid-rich sunflower oil diet compared with an oleic acid-rich olive oil diet. Diabetes Care. 2000;23(10):1472-7. [PubMed]
59. Sato K, Arai H, Mizuno A, Fukaya M, Sato T, Koganei M, Et al. Dietary palatinose and oleic acid ameliorate disorders of glucose and lipid metabolism in Zucker fatty rats. J Nutr. 2007;137(8):1908-15. [PubMed]
60. Zivkovic AM, German JB, Sanyal AJ. Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. Am J Clin Nutr. 2007;86(2):285-300. [PubMed]
61. Galal O. Nutrition-related health patterns in the Middle East. Asia Pac J Clin Nutr. 2003;12(3):337-43. [PubMed]
62. Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi F. Dietary diversity score and cardiovascular risk factors in Tehranian adults. Public Health Nutr. 2006;9(6):728-36. [PubMed]
63. Esmaillzadeh A, Azadbakht L. Consumption of hydrogenated versus nonhydrogenated vegetable oils and risk of insulin resistance and the metabolic syndrome among Iranian adult women. Diabetes Care. 2008;31(2):223-6. [DOI] [PubMed]
64. Ghassemi H, Harrison G, Mohammad K. An accelerated nutrition transition in Iran. Public Health Nutr.2002;5(1A):149-55. [DOI] [PubMed]
65. Esmaillzadeh A, Azadbakht L. Major dietary patterns in relation to general obesity and central adiposity among Iranian women. J Nutr. 2008;138(2):358-63. [PubMed]
66. Esmaillzadeh A, Kimiagar M, Mehrabi Y, Azadbakht L, Hu FB, Willett WC. Dietary patterns, insulin resistance, and prevalence of the metabolic syndrome in women. Am J Clin Nutr. 2007;85(3):910-8. [PubMed]
67. Esmaillzadeh A, Kimiagar M, Mehrabi Y, Azadbakht L, Hu FB, Willett WC. Dietary patterns and markers of systemic inflammation among Iranian women. J Nutr. 2007;137(4):992-8. [PubMed]
68. Azadbakht L, Esmaillzadeh A. Dietary and non-dietary determinants of central adiposity among Tehrani women. Public Health Nutr. 2008;11(5):528-34. [DOI] [PubMed]
69. Hu FB. Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care. 2011;34(6):1249-57. [DOI] [PubMed]
70. Bortolotti M, Kreis R, Debard C, Cariou B, Faeh D, Chetiveaux M, Et al. High protein intake reduces intrahepatocellular lipid deposition in humans. Am J Clin Nutr. 2009;90(4):1002-10. [DOI] [PubMed]
71. Schwarz J, Tome D, Baars A, Hooiveld GJ, Muller M. Dietary protein affects gene expression and prevents lipid accumulation in the liver in mice. PLoS One. 2012;7(10):Eee47303 [DOI] [PubMed]
72. Lockwood DH, Amatruda JM, Moxley RT, Pozefsky T, Boitnott JK. Effect of oral amino acid supplementation on liver disease after jejunoileal bypass for morbid obesity. Am J Clin Nutr. 1977;30(1):58-63. [PubMed]
73. Meghelli-Bouchenak M, Belleville J, Boquillon M. Hepatic steatosis and serum very low density lipoproteins during two types of protein malnutrition followed by balanced refeeding. Nutrition. 1989;5(5):321-9. [PubMed]
74. Uebanso T, Taketani Y, Fukaya M, Sato K, Takei Y, Sato T, Et al. Hypocaloric high-protein diet improves fatty liver and hypertriglyceridemia in sucrose-fed obese rats via two pathways. Am J Physiol Endocrinol Metab.2009;297(1):E76-84. [DOI] [PubMed]
75. Oz HS, Chen TS, Neuman M. Nutrition intervention: a strategy against systemic inflammatory syndrome. JPEN J Parenter Enteral Nutr. 2009;33(4):380-9. [DOI] [PubMed]
76. Cai Y, Wang Q, Ling Z, Pipeleers D, McDermott P, Pende M, Et al. Akt activation protects pancreatic beta cells from AMPK-mediated death through stimulation of mTOR. Biochem Pharmacol. 2008;75(10):1981-93. [DOI] [PubMed]
77. Leidy HJ, Mattes RD, Campbell WW. Effects of acute and chronic protein intake on metabolism, appetite, and ghrelin during weight loss. Obesity (Silver Spring). 2007;15(5):1215-25. [DOI] [PubMed]
78. Duran-Sandoval D, Cariou B, Percevault F, Hennuyer N, Grefhorst A, van Dijk TH, Et al. The farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transition. J Biol Chem.2005;280(33):29971-9. [DOI] [PubMed]
79. Longuet C, Sinclair EM, Maida A, Baggio LL, Maziarz M, Charron MJ, Et al. The glucagon receptor is required for the adaptive metabolic response to fasting. Cell Metab. 2008;8(5):359-71. [DOI] [PubMed]
80. Sanyal AJ. Mechanisms of Disease: pathogenesis of nonalcoholic fatty liver disease. Nat Clin Pract Gastroenterol Hepatol. 2005;2(1):46-53. [DOI] [PubMed]